195 related articles for article (PubMed ID: 34307380)
1. LncRNA NORAD Promotes Vascular Endothelial Cell Injury and Atherosclerosis Through Suppressing
Kai H; Wu Q; Yin R; Tang X; Shi H; Wang T; Zhang M; Pan C
Front Cell Dev Biol; 2021; 9():701628. PubMed ID: 34307380
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis.
Bian W; Jing X; Yang Z; Shi Z; Chen R; Xu A; Wang N; Jiang J; Yang C; Zhang D; Li L; Wang H; Wang J; Sun Y; Zhang C
Aging (Albany NY); 2020 Apr; 12(7):6385-6400. PubMed ID: 32267831
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR4697HG Alleviates Endothelial Cell Injury and Atherosclerosis Progression in Mice via the FUS/ANXA5 Axis.
Liu X; Huang R; Wan J; Niu T
Biochem Genet; 2023 Dec; ():. PubMed ID: 38082058
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR‑590‑3p under hypoxic conditions.
Zhao X; Wei X; Wang X; Qi G
Mol Med Rep; 2020 Jun; 21(6):2560-2570. PubMed ID: 32323787
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 silencing enhances proliferation and migration of ox-LDL-treated human umbilical vein endothelial cells and promotes atherosclerotic vascular injury repairing via the Runx2/ANPEP axis.
Du H; Yang L; Zhang H; Zhang X; Shao H
Int J Cardiol; 2021 Sep; 338():204-214. PubMed ID: 33971184
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis
Li P; Xing J; Zhang J; Jiang J; Liu X; Zhao D; Zhang Y
J Adv Res; 2020 Nov; 26():123-135. PubMed ID: 33133688
[TBL] [Abstract][Full Text] [Related]
7. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5.
Fu DN; Wang Y; Yu LJ; Liu MJ; Zhen D
Exp Cell Res; 2021 Apr; 401(2):112519. PubMed ID: 33636159
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function.
Zhou K; Li N; Qi J; Tu P; Yang Y; Duan H
Thromb J; 2024 Jan; 22(1):3. PubMed ID: 38167080
[TBL] [Abstract][Full Text] [Related]
9. EP300 improves endothelial injury and mitochondrial dysfunction in coronary artery disease by regulating histone acetylation of SOCS1 promoter via inhibiting JAK/STAT pathway.
Xue W; Deng L
Cytokine; 2024 Apr; 176():156507. PubMed ID: 38244240
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19/miR-let-7 axis participates in the regulation of ox-LDL-induced endothelial cell injury via targeting periostin.
Cao L; Zhang Z; Li Y; Zhao P; Chen Y
Int Immunopharmacol; 2019 Jul; 72():496-503. PubMed ID: 31054453
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA OIP5-AS1 accelerates the ox-LDL mediated vascular endothelial cells apoptosis through targeting GSK-3β via recruiting EZH2.
Wang M; Liu Y; Li C; Zhang Y; Zhou X; Lu C
Am J Transl Res; 2019; 11(3):1827-1834. PubMed ID: 30972206
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway.
Li H; Zhao Q; Chang L; Wei C; Bei H; Yin Y; Chen M; Wang H; Liang J; Wu Y
Lipids Health Dis; 2019 Mar; 18(1):62. PubMed ID: 30871555
[TBL] [Abstract][Full Text] [Related]
14. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
15. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
Zhang C; Yang H; Li Y; Huo P; Ma P
Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis.
Guo JT; Wang L; Yu HB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9633-9644. PubMed ID: 33015807
[TBL] [Abstract][Full Text] [Related]
17. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4.
Lu G; Tian P; Zhu Y; Zuo X; Li X
J Biosci; 2020; 45():. PubMed ID: 32345778
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-328-3p Protects Vascular Endothelial Cells Against Oxidized Low-Density Lipoprotein Induced Injury via Targeting Forkhead Box Protein O4 (FOXO4) in Atherosclerosis.
Qin X; Guo J
Med Sci Monit; 2020 Apr; 26():e921877. PubMed ID: 32329448
[TBL] [Abstract][Full Text] [Related]
19. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling.
Guo FX; Wu Q; Li P; Zheng L; Ye S; Dai XY; Kang CM; Lu JB; Xu BM; Xu YJ; Xiao L; Lu ZF; Bai HL; Hu YW; Wang Q
Cell Death Differ; 2019 Sep; 26(9):1670-1687. PubMed ID: 30683918
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE
Geng J; Fu W; Yu X; Lu Z; Liu Y; Sun M; Yu P; Li X; Fu L; Xu H; Sui D
Front Pharmacol; 2020; 11():500. PubMed ID: 32390845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
